Ivey Business School (Canada)
-
Measuring Impairment at Dofasco
Mary Gillett; Mary-Jane MastrandreaCase IVEY-9B09B017-EAccounting and ControlIn December 2008, the ArcelorMittal Dofasco (Dofasco) accounting team was facing a significant challenge. In the past few years, Dofasco had undergone significant ownership changes, and when the firm had first been acquired the market had placed a premium share value on the Dofasco subsidiary. In light of a recent economic downturn, the accounting team was required to reassess the values assigned to the subsidiary's net assets. Dismal forecasted ...Starting at €8.20
-
Internationalization of Logset Oy
Bonita Russell; Cory IsaacsCase IVEY-9B17M175-EStrategyLogset Oy (Logset) was a privately held, specialized forest-machine manufacturing firm in Koivulahti, Finland. The firm had a strong presence in Europe but not in North America. Canada, with 42 per cent of its land mass covered by forest, was an appealing market, although 15 years of effort had not resulted in any appreciable increase in sales there. Logset had a strong dealer network in Ontario and Quebec. However, efforts to recruit a dealer fo...Starting at €8.20
-
Junkkari Oy: Growing the Wood-Chipper Business
Bonita Russell; Cory IsaacsCase IVEY-9B18M131-EStrategyThe MSK Group Oy was a third-generation family-owned business located in Ylihärmä, Finland. One of its subsidiaries, Junkkari Oy (Junkkari), manufactured agricultural and forestry equipment, including a range of mid-sized disk wood chippers used in small-scale farming and forestry applications; most of these were exported to markets in Europe and South Africa. Junkkari was not the only Finnish firm manufacturing wood chippers, and there was littl...Starting at €8.20
-
Accounting at Biovail - Revised
Mary Gillett; Mary-Jane Mastrandrea; Jessica FrischCase IVEY-9B09B004-EAccounting and ControlBiovail was a large international pharmaceutical company with reported revenues of $788 million. Banc of America has issued a research report which indicates that Biovail Corporation's financial statements raised a number of issues that warrant caution for investors, and as a result, Biovail's stock was given a sell rating by Banc of America. A member of Biovail's audit committee is preparing for an upcoming audit meeting and considers the implic...Starting at €8.20